Keynote-U01: A Phase 2 Umbrella Study Of Investigational Agents Plus Pembrolizumab-Based Therapy For Advanced Nsclc

JOURNAL OF THORACIC ONCOLOGY(2021)

Cited 0|Views10
No score
Key words
nonesmall-cell lung cancer, pembrolizumab, investigational agent
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined